These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 10900392)
1. Association between a polymorphism of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) gene and sporadic Parkinson's disease. Zhang J; Hattori N; Leroy E; Morris HR; Kubo S; Kobayashi T; Wood NW; Polymeropoulos MH; Mizuno Y Parkinsonism Relat Disord; 2000 Oct; 6(4):195-197. PubMed ID: 10900392 [TBL] [Abstract][Full Text] [Related]
2. A polymorphic variation of serine to tyrosine at codon 18 in the ubiquitin C-terminal hydrolase-L1 gene is associated with a reduced risk of sporadic Parkinson's disease in a Japanese population. Satoh J; Kuroda Y J Neurol Sci; 2001 Aug; 189(1-2):113-7. PubMed ID: 11535241 [TBL] [Abstract][Full Text] [Related]
3. Genetic association between Ubiquitin Carboxy-terminal Hydrolase-L1 gene S18Y polymorphism and sporadic Alzheimer's disease in a Chinese Han population. Xue S; Jia J Brain Res; 2006 May; 1087(1):28-32. PubMed ID: 16626667 [TBL] [Abstract][Full Text] [Related]
4. [Association of the ubiquitin carboxy-terminal hydrolase-L1 genetic polymorphism with the susceptibility of Parkinson's disease]. Xiao Y; Zhang B Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):586-7. PubMed ID: 18841579 [TBL] [Abstract][Full Text] [Related]
5. No genetic association of the ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism with familial Parkinson's disease. Levecque C; Destée A; Mouroux V; Becquet E; Defebvre L; Amouyel P; Chartier-Harlin MC J Neural Transm (Vienna); 2001; 108(8-9):979-84. PubMed ID: 11716150 [TBL] [Abstract][Full Text] [Related]
6. The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson's disease. Mellick GD; Silburn PA Neurosci Lett; 2000 Oct; 293(2):127-30. PubMed ID: 11027850 [TBL] [Abstract][Full Text] [Related]
7. [Association of two polymorphisms in ubiquitin carboxy-terminal hydrolase-L1 gene with Parkinson's disease in Shanghai]. Hao YX; Zhang J; Fang CP; Zhang Q; Zhang JR; Shen Q Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):272-5. PubMed ID: 18543214 [TBL] [Abstract][Full Text] [Related]
8. Insights into links between familial and sporadic Parkinson's disease: physical relationship between UCH-L1 variants and chaperone-mediated autophagy. Kabuta T; Wada K Autophagy; 2008 Aug; 4(6):827-9. PubMed ID: 18635949 [TBL] [Abstract][Full Text] [Related]
9. S18Y in ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) associated with decreased risk of Parkinson's disease in Sweden. Carmine Belin A; Westerlund M; Bergman O; Nissbrandt H; Lind C; Sydow O; Galter D Parkinsonism Relat Disord; 2007 Jul; 13(5):295-8. PubMed ID: 17287139 [TBL] [Abstract][Full Text] [Related]
10. Failure to find mutations in ubiquitin carboxy-terminal hydrolase L1 gene in familial Parkinson's disease. Zhang J; Hattori N; Giladi N; Mizuno Y Parkinsonism Relat Disord; 2000 Oct; 6(4):199-200. PubMed ID: 10900393 [TBL] [Abstract][Full Text] [Related]
11. Endogenous neurotoxic dopamine derivative covalently binds to Parkinson's disease-associated ubiquitin C-terminal hydrolase L1 and alters its structure and function. Contu VR; Kotake Y; Toyama T; Okuda K; Miyara M; Sakamoto S; Samizo S; Sanoh S; Kumagai Y; Ohta S J Neurochem; 2014 Sep; 130(6):826-38. PubMed ID: 24832624 [TBL] [Abstract][Full Text] [Related]
12. Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants. Nishikawa K; Li H; Kawamura R; Osaka H; Wang YL; Hara Y; Hirokawa T; Manago Y; Amano T; Noda M; Aoki S; Wada K Biochem Biophys Res Commun; 2003 Apr; 304(1):176-83. PubMed ID: 12705903 [TBL] [Abstract][Full Text] [Related]
13. ACT and UCH-L1 polymorphisms in Parkinson's disease and age of onset. Wang J; Zhao CY; Si YM; Liu ZL; Chen B; Yu L Mov Disord; 2002 Jul; 17(4):767-71. PubMed ID: 12210873 [TBL] [Abstract][Full Text] [Related]
15. Case-control study of UCHL1 S18Y variant in Parkinson's disease. Tan EK; Puong KY; Fook-Chong S; Chua E; Shen H; Yuen Y; Pavanni R; Wong MC; Puvan K; Zhao Y Mov Disord; 2006 Oct; 21(10):1765-8. PubMed ID: 16941465 [TBL] [Abstract][Full Text] [Related]
16. Backbone and side-chain 1H, 15N and 13C resonance assignments of S18Y mutant of ubiquitin carboxy-terminal hydrolase L1. Tse HS; Hu HY; Sze KH Biomol NMR Assign; 2011 Oct; 5(2):165-8. PubMed ID: 21298373 [TBL] [Abstract][Full Text] [Related]
17. Effects of UCH-L1 on alpha-synuclein over-expression mouse model of Parkinson's disease. Yasuda T; Nihira T; Ren YR; Cao XQ; Wada K; Setsuie R; Kabuta T; Wada K; Hattori N; Mizuno Y; Mochizuki H J Neurochem; 2009 Feb; 108(4):932-44. PubMed ID: 19141079 [TBL] [Abstract][Full Text] [Related]
18. CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders. Mondello S; Constantinescu R; Zetterberg H; Andreasson U; Holmberg B; Jeromin A Parkinsonism Relat Disord; 2014 Apr; 20(4):382-7. PubMed ID: 24507721 [TBL] [Abstract][Full Text] [Related]
19. The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease. Harhangi BS; Farrer MJ; Lincoln S; Bonifati V; Meco G; De Michele G; Brice A; Dürr A; Martinez M; Gasser T; Bereznai B; Vaughan JR; Wood NW; Hardy J; Oostra BA; Breteler MM Neurosci Lett; 1999 Jul; 270(1):1-4. PubMed ID: 10454131 [TBL] [Abstract][Full Text] [Related]
20. UCH-L1 S18Y variant and risk of Parkinson's disease in Asian populations: an updated meta-analysis. Zhu R; Zhu Y; Liu X; He Z Neurodegener Dis; 2014; 14(4):194-203. PubMed ID: 25471998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]